tiprankstipranks
Trending News
More News >
Nectar Lifesciences Ltd. (IN:NECLIFE)
:NECLIFE
India Market

Nectar Lifesciences Ltd. (NECLIFE) Financial Statements

Compare
1 Followers

Nectar Lifesciences Ltd. Financial Overview

Nectar Lifesciences Ltd.'s market cap is currently ₹4.09B. The company's EPS TTM is ₹-7.848; its P/E ratio is -1.13; Nectar Lifesciences Ltd. is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 16.70B₹ 16.84B₹ 15.24B₹ 16.69B₹ 15.43B
Gross Profit₹ 3.02B₹ 4.82B₹ 579.91M₹ 2.99B₹ 2.58B
Operating Income₹ -888.47M₹ 3.89B₹ -40.98M₹ 1.02B₹ 620.13M
EBITDA₹ -245.66M₹ 1.69B₹ 994.97M₹ 1.61B₹ 612.51M
Net Income₹ -1.14B₹ 49.95M₹ -241.83M₹ 250.47M₹ -732.64M
Balance Sheet
Cash & Short-Term Investments₹ 272.63M₹ 203.01M₹ 178.94M₹ 182.35M₹ 259.58M
Total Assets₹ 20.47B₹ 21.91B₹ 21.89B₹ 23.91B₹ 23.88B
Total Debt₹ 5.82B₹ 6.36B₹ 7.54B₹ 8.60B₹ 9.03B
Net Debt₹ 5.63B₹ 6.16B₹ 7.36B₹ 8.42B₹ 8.78B
Total Liabilities₹ 10.91B₹ 11.22B₹ 11.25B₹ 13.03B₹ 13.26B
Stockholders' Equity₹ 9.56B₹ 10.69B₹ 10.65B₹ 10.88B₹ 10.62B
Cash Flow
Free Cash Flow₹ 1.26B₹ 1.95B₹ 1.04B₹ 700.35M₹ -98.62M
Operating Cash Flow₹ 1.69B₹ 2.25B₹ 1.34B₹ 950.05M₹ 213.79M
Investing Cash Flow₹ -419.30M₹ -170.25M₹ 517.04M₹ 166.44M₹ -286.24M
Financing Cash Flow₹ -1.28B₹ -2.05B₹ -1.86B₹ -1.19B₹ 114.90M
Currency in INR

Nectar Lifesciences Ltd. Earnings and Revenue History

Nectar Lifesciences Ltd. Debt to Assets

Nectar Lifesciences Ltd. Cash Flow

Nectar Lifesciences Ltd. Forecast EPS vs Actual EPS